Risk factors of poor prognosis in patients with pyrrolidine alkaloids induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt : Transjugular intrahepatic portosystemic shunt in patients with sinusoidal obstruction syndrome, etiology matters

Affiliations

• ¹ Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital ClínicInstitut de Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Villarroel 170, 08036, Barcelona, Spain.
• ² CIBEREHD (Centro de Investigación Biomédica en Red Enfermedades Hepáticas Y Digestivas), Barcelona, Spain.
• ³ Health Care Provider of the European Reference Network On Rare Liver Disorders (ERN-Liver), Paris, France.
• ⁴ Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital ClínicInstitut de Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Villarroel 170, 08036, Barcelona, Spain. [email protected].
• ⁵ CIBEREHD (Centro de Investigación Biomédica en Red Enfermedades Hepáticas Y Digestivas), Barcelona, Spain. [email protected].
• ⁶ Health Care Provider of the European Reference Network On Rare Liver Disorders (ERN-Liver), Paris, France. [email protected].